| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.29 | 0.05 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |